Leverage Shares 2X Long FIX Daily ETF (BATS:FIXX) CFO Sells $65,776.32 in Stock

Leverage Shares 2X Long FIX Daily ETF (BATS:FIXX) CFO Lee Kalowski sold 3,972 shares of the business’s stock in a transaction that occurred on Tuesday, August 25th. The stock was sold at an average price of $16.56, for a total value of $65,776.32. Following the transaction, the chief financial officer owned 138,471 shares of the company’s stock, valued at approximately $2,293,079.76. This represents a 2.79% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Leverage Shares 2X Long FIX Daily ETF Stock Performance

FIXX opened at $11.27 on Friday. Leverage Shares 2X Long FIX Daily ETF has a 12 month low of $11.27 and a 12 month high of $14.30.

Homology Medicines, Inc was a clinical-stage biotechnology company focused on developing genetic medicines for patients with rare diseases. The company sought to use its proprietary human-derived adeno-associated virus vectors, known as AAVHSCs, to deliver gene therapies in vivo and address the underlying causes of inherited disorders.

Its development programs included HMI-103, an investigational gene therapy for phenylketonuria, as well as earlier programs targeting other rare diseases.